Express News | Guangdong Hec Technology Holding: Guanggu East Smart has signed a "Siasun Robot&Automation Project Agreement" with Hubei Ke Investment Group for no more than 70 million yuan. The first batch of humanoid robot Orders has been finalized.

BreakingsMar 31 13:17

The "Innovative Drugs + AI Medical" Global Strategy has gained recognition from "Northern Water," exploring the allocation logic after the annual report of HEC CJ PHARM (01558).

HEC CJ PHARM has continued to attract interest from Hong Kong Stock Connect funds, primarily due to the "Innovative Drugs + AI Medical" development strategy actively promoted by the company in recent years. Therefore, investors can use this as a starting point to explore the continuously increasing investment certainty in the company's latest disclosed 2024 annual report.

Zhitong FinanceMar 31 09:10

The performance of Guangdong Hec Technology Holding (01558.HK) shows a net profit of 0.483 billion yuan for the whole year, a decrease of 75.8%.

HEC CJ PHARM (01558.HK) announced its full-year results for the year ending last December, with revenues of 3.724 billion yuan (RMB), a year-on-year decrease of 40.8%. Net profit was 0.483 billion yuan, a year-on-year decrease of 75.8%; earnings per share were 0.55 yuan. No dividend was declared.

AASTOCKSMar 30 23:40

HEC CJ PHARM (01558) released its annual performance, with a profit attributable to Shareholders of 0.483 billion yuan.

HEC CJ PHARM (01558) announced the annual performance for the year ending December 31, 2024, with operating revenue...

Zhitong FinanceMar 29 01:20

HEC CJ PHARM (01558): Acalabrutinib tablets (0.3g) have been approved for market launch.

HEC CJ PHARM (01558) announced that the product, Acalabrutinib tablets (0.3...

Zhitong FinanceMar 27 21:06

Express News | Guangdong Hec Technology Holding's Guanggu Dongzhi will hold a humanoid robot launch conference in May, capable of thinking like a human with the support of embodied intelligent technology.

BreakingsMar 26 10:26